Table 1.
Titre of West Nile virus (WNV) antigen-specific antibodies in sera of immunized mice with or without challenge with WNV
| Vaccination | WNV challenge | Date of sera harvest | Antibody titre |
|---|---|---|---|
| No treatment | – | Negative control1 | |
| p458 | – | 7 days after 3rd immunization | Negative control1 |
| p458-Ep15 | – | 7 days after 3rd immunization | 25 600 |
| Ep15 | – | 7 days after 3rd immunization | Not detected2 |
| p431-Ep15 | – | 7 days after 3rd immunization | Not detected2 |
| p458-Ep15 | 104 PFU | 10 days after challenge | 51 200 |
| Ep15 | 104 PFU | 10 days after challenge | 3200 |
| p431-Ep15 | 104 PFU | 10 days after challenge | 6400 |
| p458 | 104 PFU | 10 days after challenge | 1600 |
Three-week-old mice were immunized three times with the different peptides (equimolar amounts, emulsified in incomplete Freund’s adjuvant), at 7-day intervals. Seven days after the last immunization, the mice were bled and then challenged intraperitoneally with a lethal dose of WNV-ISR98 strain. Ten days after the challenge, surviving mice were bled, sera from each group were pooled and tested by enzyme-linked immunosorbent assay as described in the Materials and methods.
For calculation of cut-offs at a confidence level of 99·5%,62 we employed two negative controls, namely pooled sera from (i) naive mice and (ii) p458-immunized mice.
The detection level for WNV antigen-specific antibody titre in this experiment was 400.
PFU, plaque-forming units